Literature DB >> 2372287

Over-expression of facilitative glucose transporter genes in human cancer.

T Yamamoto1, Y Seino, H Fukumoto, G Koh, H Yano, N Inagaki, Y Yamada, K Inoue, T Manabe, H Imura.   

Abstract

The expression of five facilitative glucose transporter genes, GLUT1 (erythrocyte type), GLUT2 (liver type), GLUT3 (brain type), GLUT4 (muscle/fat type), and GLUT5 (small intestine type), was examined in human cancer tissues of the digestive system by RNA blotting analysis. The amounts of the GLUT1, GLUT2, and GLUT3 transcripts were elevated in most cancer tissues studied, although the expression of the GLUT2 gene is primarily restricted to the liver. On the other hand, mRNA levels of GLUT4 and GLUT5 were below sensitivity in all cancer tissues examined. These results suggest that over-expression of GLUT1 and GLUT3 might be closely related with tissue development and that the acceleration of glucose uptake by transformed cells may result, at least in part, from the increase in the expression of these two glucose transporters.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2372287     DOI: 10.1016/0006-291x(90)91263-r

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  109 in total

1.  Messenger RNA expression of transporter and ion channel genes in undifferentiated and differentiated Caco-2 cells compared to human intestines.

Authors:  Pascale Anderle; Vera Rakhmanova; Katie Woodford; Noa Zerangue; Wolfgang Sadée
Journal:  Pharm Res       Date:  2003-01       Impact factor: 4.200

2.  Multiple-drug-resistance phenomenon in the yeast Saccharomyces cerevisiae: involvement of two hexose transporters.

Authors:  A Nourani; M Wesolowski-Louvel; T Delaveau; C Jacq; A Delahodde
Journal:  Mol Cell Biol       Date:  1997-09       Impact factor: 4.272

3.  Independent prognostic value of pre-treatment 18-FDG-PET in high-grade gliomas.

Authors:  Cécile Colavolpe; Philippe Metellus; Julien Mancini; Maryline Barrie; Céline Béquet-Boucard; Dominique Figarella-Branger; Olivier Mundler; Olivier Chinot; Eric Guedj
Journal:  J Neurooncol       Date:  2011-12-15       Impact factor: 4.130

4.  Requirements for clinical PET: comparisons within Europe.

Authors:  Michael Bedford; Michael N Maisey
Journal:  Eur J Nucl Med Mol Imaging       Date:  2004-02       Impact factor: 9.236

5.  Polarized distribution of glucose transporter isoforms in Caco-2 cells.

Authors:  D S Harris; J W Slot; H J Geuze; D E James
Journal:  Proc Natl Acad Sci U S A       Date:  1992-08-15       Impact factor: 11.205

6.  Boronic acid based modular fluorescent sensors for glucose.

Authors:  Marcus D Phillips; Tony D James
Journal:  J Fluoresc       Date:  2004-09       Impact factor: 2.217

7.  Coregulation of glucose uptake and vascular endothelial growth factor (VEGF) in two small-cell lung cancer (SCLC) sublines in vivo and in vitro.

Authors:  M W Pedersen; S Holm; E L Lund; L Højgaard; P E Kristjansen
Journal:  Neoplasia       Date:  2001 Jan-Feb       Impact factor: 5.715

8.  Is serous cystadenoma of the pancreas a model of clear-cell-associated angiogenesis and tumorigenesis?

Authors:  Duangpen Thirabanjasak; Olca Basturk; Deniz Altinel; Jeanette D Cheng; N Volkan Adsay
Journal:  Pancreatology       Date:  2008-12-13       Impact factor: 3.996

9.  Can dedicated breast PET help to reduce overdiagnosis and overtreatment by differentiating between indolent and potentially aggressive ductal carcinoma in situ?

Authors:  Lucía Graña-López; Michel Herranz; Inés Domínguez-Prado; Sonia Argibay; Ángeles Villares; Manuel Vázquez-Caruncho
Journal:  Eur Radiol       Date:  2019-08-02       Impact factor: 5.315

10.  Expression of GLUT1 is associated with increasing grade of malignancy in non-invasive and invasive urothelial carcinomas of the bladder.

Authors:  Henning Reis; Stephan Tschirdewahn; Tibor Szarvas; Herbert Rübben; Kurt Werner Schmid; Florian Grabellus
Journal:  Oncol Lett       Date:  2011-08-29       Impact factor: 2.967

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.